Anett Sefrin - Publications

Tacrolimus After rATG and Infliximab Induction Immunosuppression-RIMINI Trial.

Journal: Transplantation

Published: August 01, 2023

On the clinical relevance of using complete high-resolution HLA typing for an accurate interpretation of posttransplant immune-mediated graft outcomes.

Journal: Frontiers in immunology

Published: April 20, 2022

Tacrolimus CYP3A Single-Nucleotide Polymorphisms and Preformed T- and B-Cell Alloimmune Memory Improve Current Pretransplant Rejection-Risk Stratification in Kidney Transplantation.

Journal: Frontiers in immunology

Published: February 04, 2022

Preformed T cell alloimmunity and HLA eplet mismatch to guide immunosuppression minimization with tacrolimus monotherapy in kidney transplantation: Results of the CELLIMIN trial.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: January 04, 2021

Regulatory T cells for minimising immune suppression in kidney transplantation: phase I/IIa clinical trial.

Journal: BMJ (Clinical research ed.)

Published: October 22, 2020

Differential T cell response against BK virus regulatory and structural antigens: A viral dynamics modelling approach.

Journal: PLoS computational biology

Published: March 15, 2017

Inflammatory activation and recovering BKV-specific immunity correlate with self-limited BKV replication after renal transplantation.

Journal: Transplant international : official journal of the European Society for Organ Transplantation

Published: July 22, 2013

Vitamin A metabolism is changed in donors after living-kidney transplantation: an observational study.

Journal: Lipids in health and disease

Published: November 01, 2011